EUObserver reports that the European Medicines Agency has reversed its long-held stance on releasing studies on drug side effects after pressure from the European Ombudsman. The London-based agency, which evaluates drugs in the EU, on Wednesday (11 August) said that it would issue data on anti-acne medication Roaccutane produced by pharma giant Roche in the coming weeks.
Read more here: http://euobserver.com/9/30613/?rk=1
I've left Google
-
My nearly 2 decades at Google as its Global Privacy Counsel has ended.
I’ve left Google as one of the last few remaining members of the original
early G...
13 hours ago
No comments:
Post a Comment